The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?
ABSTRACT: Background: In the search for new antidepressants, clinical researchers have been using drugs that simultaneously modulate multiple targets. During preclinical and clinical trials, the glutamatergic modulators riluzole and ketamine have received particular attention. Glutamatergic agents h...
Saved in:
Main Author: | Marcos Emilio Frizzo, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
by: Marcos Emilio Frizzo, PhD
Published: (2017) -
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
by: Shigeyuki Chaki, et al.
Published: (2015) -
Perisynaptic astrocytes as a potential target for novel antidepressant drugs
by: Marcos E. Frizzo, et al.
Published: (2021) -
Dopamine and Serotonin-Induced Modulation of GABAergic and Glutamatergic Transmission in the Striatum and Basal Forebrain
by: Toshihiko Momiyama, et al.
Published: (2017) -
Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed mice
by: Xiu-Fang Ding, et al.
Published: (2017)